0001179110-21-000428.txt : 20210108 0001179110-21-000428.hdr.sgml : 20210108 20210108083540 ACCESSION NUMBER: 0001179110-21-000428 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lutz Robert Matthew CENTRAL INDEX KEY: 0001786203 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37569 FILM NUMBER: 21515765 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE STREET 2: SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 4 1 edgar.xml FORM 4 - X0306 4 2021-01-07 0 0001634432 Strongbridge Biopharma plc SBBP 0001786203 Lutz Robert Matthew 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 0 1 0 0 Chief Financial Officer Ordinary Shares 2021-01-07 4 A 0 147500 0 A 188311 D Represents a grant of restricted stock units, which vest in full on January 7, 2023, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. /s/ Judith Goldberg, as attorney-in-fact 2021-01-08